Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsThe LCP is currently in the tendering phase, with construction expected to start in the second half of 2026. Commercial operations are scheduled for 2028.
ocal petrochemical company PT Lintas Citra Pratama (LCP) has started to develop a US$300 million (Rp 5 trillion) polyethylene terephthalate (PET) plant as part of its long-term strategy to reduce reliance on imported raw materials.
The facility, which will have an annual production capacity of up to 720,000 tonnes, will be built on land owned by LCP’s subsidiary PT Merak Chemical Indonesia (MCCI) in Banten.
MCCI described the project as a “pivotal moment” for both the company and Indonesia’s broader industrial ambitions, noting that the domestic market still depends heavily on PET imports for key manufacturing sectors.
PET is a transparent thermoplastic polymer commonly used in textiles as well as in packaging for food and beverage containers.
“This downstream push will not only create added value for the company but also strengthen Indonesia’s position in the regional industrial chain,” MCCI president director Anang Adji Sunoto said on Monday, as quoted by Antara.
Read also: Combating illegal imports of manufactured products
The investment aligns with President Prabowo Subianto’s call to accelerate integrated downstream development, particularly in strategic sectors where Indonesia continues to face structural deficits.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.